Granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in β-thalassemia patients: Kinetics of mobilization and composition of apheresis product

Experimental Hematology

Volumn 27, Issue 3, 1999, Pages 526-532

  Li, Karen ^a   Wong, Annie ^a   Li, Chi Kong ^a   Shing, Matthew Ming Kong ^a   Chik, Ki Wai ^a   Tsang, Kam Sze ^a   Lai, Howard ^a   Leung, Ting Fan ^a   Yuen, Patrick Man Pan ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Thalassemia; Granulocyte colony stimulating factor; Peripheral blood stem cell

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

APHERESIS; ARTICLE; BETA THALASSEMIA; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOMODULATION; LYMPHOCYTE DIFFERENTIATION; MALE; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SCHOOL CHILD; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; ADULT; BETA-THALASSEMIA; BLOOD CELL COUNT; BLOOD CELLS; CHILD; CHILD, PRESCHOOL; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; INFANT; LEUKAPHERESIS; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MALE; RECOMBINANT PROTEINS;

EID: 0033048789     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(98)00045-9     Document Type: Article

References (34)

1. Thomas E.D., Buckner C.D., Sanders J.E., Papayannopoulou T., Borgna-Pignatti C., De Stefano P., Sullivan K.M., Clift R.A., Storb R. Marrow transplantation for thalassaemia. Lancet. 2:1982;227.
2. Lucarelli G., Galimberti M., Polchi P., Angelucci E., Baronciana D., Giardini C., Politi P., Durazzi S.M.T., Muretto P., Albertini F. Bone marrow transplantation in patients with thalassaemia. N Engl J Med. 322:1990;417.
3. Lucarelli G., Giardini C., Baronciani D. Bone marrow transplantation in thalassemia. Semin Hematol. 32:1995;297.
4. Beuzard Y. Towards gene therapy of hemoglobinopathies. Semin Hematol. 33:1996;43.
5. Bregni M., Magni M., Siena S., Di Nicola M., Bonadonna G., Gianni A.M. Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer. Blood. 80:1992;1418.
6. Cassel A., Cottler-Fox M., Doren S., Dunbar C.E. Retroviral mediated gene transfer into CD34-enriched human peripheral blood stem cells. Exp Hematol. 21:1993;585.
7. + progenitors to peripheral blood. impaired mobilization in chronic granulomatous disease and adenosine deaminase-deficient severe combined immunodeficiency disease patients Blood. 88:1996;1104.
8. De Martino M., Rossi M.E., Muccioli A.T., Vullo C., Vierucci A. Altered T cell subsets and function in polytransfused β-thalassemia patients. correlation with sex and age at first transfusion Vox Sang. 48:1995;290.
9. Grady R.W., Akbar A.N., Giardina P.J., Hilgartner M.W., De Sousa M. Disproportionate lymphoid cell subsets in thalassaemia major. the relative contributions of transfusion and splenectomy Br J Haematol. 59:1995;713.
10. Kaminski E.R., Hows J.M., Goldman J.M., Batchelor J.R. Lymphocytes from multi-transfused patients exhibit cytotoxicity against autologous cells. Br J Haematol. 81:1992;23.
11. Uguccioni M., Meliconi R., Nesci S., Lucarelli G., Ceska M., Gasbarrini G., Facchini A. Elevated interleukin-8 serum concentrations in β-thalassemia and graft-versus-host disease. Blood. 9:1993;2252.
12. Lombardi G., Matera R., Minervini M.M., Cascavilla N., D'Arcangelo P., Carotenuto M., Giorgio G., Musto P. Serum levels of cytokines and soluble antigens in poly-transfused patients with β-thalassemia major:relationship to immune status. Haematologica. 79:1994;406.
13. Dwyer J., Wood C., McNamara J., Williams A., Andiman W., Rink L., O'Connor T., Pearson H. Abnormalities in the immune system of children with beta-thalassaemia major. Clin Exp Immunol. 68:1997;621.
14. Speer C.P., Gahr M., Schuff-Werner P., Schröter W. Immunologic evaluation of children with homozygous beta-thalassemia treated with desferrioxamine. Acta Haematol. 83:1990;76.
15. Li K., Li C.K., Wong R.P.O., Wong A., Shing M.M.K., Chik K.W., Yuen P.M.P. Transfusion-related immunomodulation in Chinese children with thalassaemia. Vox Sang. 73:1997;135.
16. Li C.K., Yuen P.M.P., Chik K.W., Shing M.M.K., Li K., Tsang K.S., Wong A., Leung T.F., Lai H. Allogeneic peripheral blood stem cell transplant in children. Med Pediatr Oncol. 30:1998;147.
17. Dreger P., Haferlach T., Eckstein V., Jacobs S., Suttorp M., Löffler H., Müller-Ruchholtz W., Schmitz N. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation. safety, kinetics of mobilization, and composition of the graft Br J Haematol. 87:1994;609.
18. Lane T.A., Law P., Maruyama M., Young D., Burgess J., Mullen M., Mealiffe M., Terstappen L.W.M.M., Hardwick A., Moubayed M., Oldham F., Corringham R.E.T., Ho A.D. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF. potential role in allogeneic marrow transplantation Blood. 85:1995;275.
19. Majolino I., Scimé R., Vasta S., Cavallaro A.M., Fiandaca T., Indovina A., Catania P., Santoro A. Mobilization and collection of PBSC in healthy donors. comparison between two schemes of rhG-CSF administration Eur J Haematol. 57:1996;214.
20. + peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor. Blood. 84:1994;2795.
21. + subsets in leukapheresis products mobilized by G-CSF, GM-CSF vs. a combination of both. Exp Hematol. 24:1996;1460.
22. dim) and lymphocyte subsets, and possible predictors of engraftment and graft-versus-host disease Blood. 86:1995;2842.
23. + cells after stem cell mobilization predict stem cell yield and postransplant hematopoietic recovery. J Hematother. 6:1997;13.
24. Grigg A.P., Roberts A.W., Raunow H., Houghton S., Layton J.E., Boyd A.W., McGrath K.M., Maher D. Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers. Blood. 86:1995;4437.
25. + progenitor cells and lymphoid subsets in normal donors for allogeneic transplantation. Br J Haematol. 93:1996;940.
26. Mehta J., Powles R., Singhal S., Horton C., Treleaven J. Outcome of autologous rescue after failed engraftment of allogeneic marrow. Bone Marrow Transplant. 17:1996;213.
27. Anderlini P., Przepiorka D., Champlin R., Körbling M. Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals. Blood. 88:1996;2819.
28. Kuwabara T., Kobayashi S., Sugiyama Y. Pharmacokinetics and pharmacodynamics of a recombinant human granulocyte colony-stimulating factor. Drug Metab Rev. 28:1996;625.
29. Demetri G.D., Griffin J.D. Granulocyte colony-stimulating factor and its receptor. Blood. 78:1991;2791.
30. 125I-labeled granulocyte colony-stimulating factor to normal murine hemopoietic cells. J Cell Physiol. 124:1985;313.
31. Avalos B.R. Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood. 88:1996;761.
32. Elbaz O., Budel L.M., Hoogerbrugge H., Touw I.P., Delwel R., Mahmoud L.A., Löwenberg B. Tumor necrosis factor downregulates granulocyte colony-stimulating factor receptor expression on human acute myeloid leukemia cells and granulocytes. J Clin Invest. 87:1991;838.
33. Broxmeyer H.E., Williams D.E., Lu L., Cooper S., Anderson S.L., Beyer G.S., Hoffman R., Rubin B.Y. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia. synergism of tumor necrosis factor and interferon-γ J Immunol. 136:1986;4487.
34. Rusten L.S., Jacobsen F.W., Lesslauer W., Loetscher H., Smeland E.B., Jacobsen S.E.W. Bifunctional effects of TNF-α on the growth of mature and primitive human hematopoietic progenitor cells. Involvement of p55 and p75 TNF receptors Blood. 83:1994;3152.